CHRS R&D Expenses
Coherus Oncology Inc · R&D Expenses
CHRS R&D Expenses
Latest reported$98.47Mperiod ending
CHRS R&D Expenses ($34.89M → $98.47M)
Annual R&D Expenses
High-resolution chart · PNG
CHRS r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 104,964,000 | |
| 93,336,000 | |
| 109,436,000 | |
| 199,358,000 | |
| 363,105,000 | |
| 142,759,000 | |
| 94,188,000 | |
| 110,239,000 | |
| 162,389,000 | |
| 254,440,000 | |
| 213,062,000 | |
| 78,224,000 | |
| 31,279,000 | |
| 34,886,000 |